Your participation in clinical trials matters—here’s why | Leigh Johnson | TEDxNYU Langone Health

Quick Overview

Leigh Johnson advocates for diversifying clinical trials by including more Black and underrepresented participants, drawing from her personal history of family members dying from preventable diseases like breast cancer and the documented historical mistreatment of Black communities in medical research, exemplified by the Tuskegee Syphilis Study, to argue that inclusive research, informed by genetic testing, is crucial for creating equitable healthcare solutions for everyone.

Key Points: Leigh Johnson's aunt, Sadie, died of breast cancer 30 years after her initial remission, highlighting the need for better, personalized treatment. Historical medical abuses, such as the 40-year untreated syphilis study on Black men (Tuskegee Study, 1932-1972), created generational mistrust in the US healthcare and research systems. In 2022, the FDA reported that only 15-20% of clinical trial participants were Black or African American, despite Black women having the highest death rates from breast cancer compared to other demographics. Johnson herself suffered from anxiety and panic attacks, finding relief through holistic treatments like talk therapy, prayer, meditation, and journaling, which she suggests should be better integrated into care. Genetic testing, which analyzes ancestral and health information, can help tailor health solutions, contrasting with the one-size-fits-all approach that fails many patients. Johnson urges scientists and the public to demand more inclusive clinical trials so that modern medicine benefits all populations, not just the demographic majority. The presentation occurred at TEDxNYU Langone Health on June 3, 2024, focusing on innovating for a healthier tomorrow.

Context: Leigh Johnson delivers a personal and research-driven talk at TEDxNYU Langone Health, focusing on the critical need to address systemic biases and lack of diversity in clinical trials. She grounds her argument in her family's history with cancer, specifically the loss of her Aunt Sadie, and the broader historical context of medical mistreatment of Black communities, such as the Tuskegee Syphilis Study, to argue that medical advancements, including genetic testing, must be inclusive to effectively treat diseases across all populations.